As of 2024-12-11, the Relative Valuation of Intellipharmaceutics International Inc (IPCI.TO) is (0.12) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 CAD, the upside of Intellipharmaceutics International Inc based on Relative Valuation is -244.6%.
The range of the Relative Valuation is (0.07) - (0.08) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.2x - 0.7x | 0.4x |
| Forward P/E multiples | 0.6x - 2.5x | 1.6x |
| Fair Price | (0.07) - (0.08) | (0.12) |
| Upside | -189.7% - -204.1% | -244.6% |
| Date | P/E |